Stroke treatment window expanded with new guidelinedoi:10.1016/j.ptdy.2018.03.003M. TanziElsevierPharmacy Today
The Heart and Stroke foundation of Canada indicates there are 62,000 strokes in Canada each year, and that 80% of people survive stroke. The Public Health Agency of Canada estimates that close to 742 000 Canadians live with the effects of stroke. A better understanding of the ways the brain...
The Heart and Stroke foundation of Canada indicates there are 62,000 strokes in Canada each year, and that 80% of people survive stroke. The Public Health Agency of Canada estimates that close to 742 000 Canadians live with the effects of stroke. A better understanding of the ways the brain...
被引量: 0发表: 2018年 Effect of intra-arterial thrombolysis following successful endovascular thrombectomy on functional outcomes in patients with large vessel occlusion acute i... ? 2023Introduction: Endovascular thrombectomy (EVT) is the standard treatment of acute ischemic stroke (AIS) due to large...
被引量: 0发表: 2018年 Acute Ischemic Stroke Treatment: State of the Art and New Options The development of experimental models of focal cerebral ischemia has allowed for a better knowledge of its pathophysiology and for testing therapeutic str... MAD Lecianaa,E Dez-Tejedorb,F Carcellerc,......
molecular mechanism of DKD, there are more and more new drugs based on this, such as new hypoglycemic drugs sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors with good efficacy in clinical treatment. Be...
This underscores the value of MR as a powerful research tool in advancing our understanding and treatment of various diseases. Plasma protein-based MR strategies have identified potential therapeutic targets for diseases such as, Type 2 diabetes and stroke [5, 9]. In a recent MR study by Yang...
Assessment of atrial fibrillation (AF)-associated stroke risk is at present mainly based on clinical risk scores such as CHADS(2) and CHA(2)DS(2)-VASc, although these scores provide only modest discrimination of risk for individual patients. Biomarkers derived from the blood may help refine ris...
The aim of this study was to evaluate the efficacy of modified mandibular advancement devices (MAD) in patients with OSA who failed treatment with MAD and to evaluate the role of the tongue as a factor in patients who failed treatment with MAD. Materials and methods Patients unable to control...
Surpass flow diverter in the treatment of intracranial aneurysms: a prospective multicenter study AJNR Am J Neuroradiol, 36 (2015), pp. 98-107 View in ScopusGoogle Scholar 12 P.M. Meyers, A.L. Coon, P.T. Kan, et al. SCENT trial Stroke, 50 (2019), pp. 1473-1479 CrossrefView in ...